MD
Mark N. Diker
Director

Mark N. Diker insider trades: Cantel Medical (CMD) stock buys and sales

Director, Cantel Medical Last trade Jan 17, 2020 62 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2008
2
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 17, 2020CMD↑ Buy$62K
Jan 17, 2020CMD↑ Buy$62K
Jan 18, 2018CMD↓ Sell$559K
Oct 3, 2017CMD↓ Sell$692K
Jun 10, 2016CMN↓ Sell$513K
Sep 30, 2015CMN↓ Sell$566K
Apr 8, 2015CMN↓ Sell$592K
Oct 1, 2013CMN↓ Sell$787K
Jun 20, 2012CMN↓ Sell$259K
Mar 7, 2008CMN↑ Buy$49K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Mark N. Diker's insider trades

Mark N. Diker is a director at Cantel Medical (CMD). Since Mar 7, 2008, Mark has reported 3 open-market purchases worth $174K and 7 sales worth $4.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include gifts (26 filings), grants and awards (21 filings), option exercises (10 filings), shares withheld for taxes (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.